UPDATE 1-Indivior wins preliminary injunction against generic rival
July 13, 2018 at 20:07 PM EDT
A U.S. court has granted Indivior a preliminary injunction blocking India's Dr. Reddy's Laboratories from selling cut-price versions of the British drugmaker's best-selling opioid addiction treatment in the United States, Indivior said on Friday.
